Literature DB >> 21586571

Peptide-protein interactions suggest that acetylation of lysines 381 and 382 of p53 is important for positive coactivator 4-p53 interaction.

Subrata Debnath1, Snehajyoti Chatterjee, Mohammed Arif, Tapas K Kundu, Siddhartha Roy.   

Abstract

The human transcriptional positive coactivator 4 (PC4) activates several p53-dependent genes. It has been demonstrated that this is a consequence of direct interaction with p53. Previously, we have concluded that PC4 interacts mainly with the C-terminal negative regulatory domain of p53 through its DNA binding C-terminal half. NMR chemical shift perturbation studies with peptide fragments indicated that amino acids 380-386 of p53 are crucial for interaction with PC4. This was verified by fluorescence anisotropy and sedimentation velocity studies. A peptide consisting of p53-(380-386) sequence, when attached to a cell penetration tag and nuclear localization signal, localizes to the nucleus and inhibits luciferase gene expression from a transfected plasmid carrying a Luc gene under a p53-dependent promoter. Acetylation of lysine 382/381 enhanced the binding of this peptide to PC4 by about an order of magnitude. NMR and mutagenesis studies indicated that serine 73 of PC4 is an important residue for recognition of p53. Intermolecular nuclear Overhauser effect placed aspartate 76 in the vicinity of lysine 381, indicating that the region around residues 73-76 of PC4 is important for p53 recognition. We conclude that the 380-386 region of p53 interacts with the region around residues 73-76 of PC4, and acetylation of lysine 382/381 of p53 may play an important role in modulating p53-PC4 interaction and as a consequence PC4 mediated activation of p53 target genes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21586571      PMCID: PMC3137081          DOI: 10.1074/jbc.M110.205328

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

Review 1.  Structure and function in the p53 family.

Authors:  C H Arrowsmith
Journal:  Cell Death Differ       Date:  1999-12       Impact factor: 15.828

2.  Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases.

Authors:  N A Barlev; L Liu; N H Chehab; K Mansfield; K G Harris; T D Halazonetis; S L Berger
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

3.  p300-mediated acetylation of human transcriptional coactivator PC4 is inhibited by phosphorylation.

Authors:  B R Kumar; V Swaminathan; S Banerjee; T K Kundu
Journal:  J Biol Chem       Date:  2001-02-14       Impact factor: 5.157

4.  Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

Authors:  Roger P Leng; Yunping Lin; Weili Ma; Hong Wu; Benedicte Lemmers; Stephen Chung; John M Parant; Guillermina Lozano; Razqallah Hakem; Samuel Benchimol
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

5.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

6.  General transcriptional coactivator PC4 activates p53 function.

Authors:  Sourav Banerjee; B R Prashanth Kumar; Tapas K Kundu
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

Review 7.  Posttranslational modification of p53: cooperative integrators of function.

Authors:  David W Meek; Carl W Anderson
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-28       Impact factor: 10.005

8.  Isotope-edited proton NMR study on the structure of a pepsin/inhibitor complex.

Authors:  S W Fesik; J R Luly; J W Erickson; C Abad-Zapatero
Journal:  Biochemistry       Date:  1988-11-01       Impact factor: 3.162

9.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

10.  The ubiquitin ligase COP1 is a critical negative regulator of p53.

Authors:  David Dornan; Ingrid Wertz; Harumi Shimizu; David Arnott; Gretchen D Frantz; Patrick Dowd; Karen O'Rourke; Hartmut Koeppen; Vishva M Dixit
Journal:  Nature       Date:  2004-04-21       Impact factor: 49.962

View more
  5 in total

Review 1.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

Review 2.  p53 N-terminal phosphorylation: a defining layer of complex regulation.

Authors:  Lisa M Miller Jenkins; Stewart R Durell; Sharlyn J Mazur; Ettore Appella
Journal:  Carcinogenesis       Date:  2012-04-12       Impact factor: 4.944

3.  An acetyl-methyl switch drives a conformational change in p53.

Authors:  Qiong Tong; Sharlyn J Mazur; Hector Rincon-Arano; Scott B Rothbart; Dmitry M Kuznetsov; Gaofeng Cui; Wallace H Liu; Yantenew Gete; Brianna J Klein; Lisa Jenkins; Georges Mer; Andrei G Kutateladze; Brian D Strahl; Mark Groudine; Ettore Appella; Tatiana G Kutateladze
Journal:  Structure       Date:  2015-02-03       Impact factor: 5.006

4.  Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons.

Authors:  Camille Brochier; Gretel Dennis; Mark A Rivieccio; Kathryn McLaughlin; Giovanni Coppola; Rajiv R Ratan; Brett Langley
Journal:  J Neurosci       Date:  2013-05-15       Impact factor: 6.167

5.  DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53.

Authors:  S K Alam; V K Yadav; S Bajaj; A Datta; S K Dutta; M Bhattacharyya; S Bhattacharya; S Debnath; S Roy; L A Boardman; T C Smyrk; J R Molina; S Chakrabarti; S Chowdhury; D Mukhopadhyay; S Roychoudhury
Journal:  Cell Death Differ       Date:  2015-10-23       Impact factor: 15.828

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.